Sponsor:
University of Alabama at Birmingham
Code:
NCT05656105
Conditions
SARS CoV-2 Post-Acute Sequelae
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Interventions
DPA-714 PET/MRI
Brief summary:
Conditions
SARS CoV-2 Post-Acute Sequelae
Study ID
NCT05656105
Start date
Nov 10, 2023
Status verified date
Aug, 2026
Completion date
Jun 1, 2028
Anticipated
Primary completion date
Jun 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
experimental: Healty Volunteers
experimental: PASC
Interventions
DPA-714 PET/MRI
Primary outcome measure
Central contacts
Locations
UAB
Recruiting
Birmingham, Alabama, United States, 35249
Contacts
Principal Investigator:
Jonathan McConathy, MD, PhD
Sponsor
University of Alabama at Birmingham
Last update posted
Aug 12, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2026-08-12.